Northern Spirits Biosciences Group Key Differentiators
Innovative Patents
Our Science Team has authored many patents and are currently leading an innovative patent pending nanotechnology-based cannabinoid delivery method for cannabis infused edible and beverage products that provides users with more accurate, faster, safer, efficient and predictable effects.
Products Based on Real Science
We only formulate, develop and sell cannabis infused edible and beverage products (including white label products) that are based on real science using our own proprietary technologies.
Formulation Experts
Our Science Team is comprised of PhD’s that are highly skilled pharmaceutical technology experts with over 25 years of experience working with cannabinoids. This allows NSBG to significantly accelerate the development of effective, targeted and safe formulations of high-grade cannabis infused products.
Press Releases
Northern Spirits Biosciences Group Announces Symbolic Launch of Corporate Website
Northern Spirits Biosciences Group is pleased to announce that the Company has symbolically chosen to launch the corporate website on October 17, 2018 at approximately 4:20 pm.
Investor Presentation
You can find our Investment Highlights Below! Simply leave us your name and email address so we can keep you up to date.
TORONTO, ONTARIO, CANADA (October 17, 2018) – Northern Spirits Biosciences Group (“NSBG” or the “Company”) is pleased to announce that the Company has symbolically chosen to launch the corporate website ( on October 17, 2018 at approximately 4:20 pm. The date is specifically of great significance as it coincides with the enactment of the Cannabis Act, which represents the first day recreational marijuana is legalized in Canada.
In addition to launching the corporate website, NSBG is officially announcing the Company’s intentions to move forward with various business and funding initiatives. Based in Oakville, Ontario, NSBG becomes the latest player to enter the Canadian cannabis space at a time where it believes that the legalization of medical and recreational marijuana in Canada has polarized the country and garnered the attention of foreign governments around the world, and where there is currently a global shift towards the general acceptance of cannabis as a legitimate alternative to conventional prescription- based drugs.
Canada is currently the only G7 country to fully legalize marijuana and management believes Canada is fast becoming the global leader in best practices for commercial licensing and governance. NSBG as a forward-looking company is laser focused on capitalizing on the emerging Canadian and global cannabis industry.
About Northern Spirits Biosciences Group
NSBG is a vertically integrated research and development (R&D), standardization and soon to be licensed producer and distributor of medical/recreational cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). NSBG is led by a motivated and passionate leadership team that has extensive government relations, quality assurance, regulatory compliance and operations experience in cannabis, natural health products, medical devices and pharma industries. NSBG currently has three distinct business verticals – R&D, product development and cannabis production.
For further information contact:
Northern Spirits Biosciences Group
Cautionary Note Regarding Forward-looking Statements
This news release may contain certain forward-looking statements and forward-looking information (collectively referred to herein as "forward-looking statements") within the meaning of applicable Canadian securities laws. All statements other than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "anticipate", "achieve", "could", "believe", "plan", "intend", "objective", "continuous", "ongoing", "estimate", "outlook", "expect", "may", "will", "project", "should" or similar words, including negatives thereof, suggesting future outcomes.
Forward looking statements are subject to both known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company, that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward looking statements. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended.
Forward-looking statements are not a guarantee of future performance and involve a number of risks and uncertainties, some of which are described herein. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company’s actual performance and results to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Any forward-looking statements are made as of the date hereof and, except as required by law, neither the Company assumes no obligation to publicly update or revise such statements to reflect new information, subsequent or otherwise.